HAVCR2 and melanoma: Our current systems biology analysis of human melanoma was conducted in an unbiased fashion to fully interrogate dysfunctional CD8+PD-1+TIM-3+ TIL (sorted) transcriptomic profiles, allowing for the identification of novel and unexpected signaling pathways that may reveal enhancement targets in more recent immune checkpoint blockade therapies.